Firm Introduces Covid-19 Vaccine Management Solution

TECH DIGEST – Epazz, a leading cloud-based software company that specializes in providing customized cloud applications to the corporate world, higher-education institutions and the public sector has introduced a Vaccine Management Solution as part of Covid-19 compliance features.

This is coming after the announcement by one of the leading pharmaceutical companies, Pfizer, that it has developed a vaccine with a promising result of 90 percent effectivity according to the company’s clinical results.

According to the company, the vaccine management software will facilitate the tracking and management of employees’ immunization against the Coronavirus. It allows employees to indicate their vaccination history through the health record management service. With the development of approved Covid-19 vaccines on the way, company administrators can monitor which team member has completed their vaccinations and which employees need a reminder to schedule and receive the Covid-19 vaccine.

“We are optimistic that adding the vaccine management software feature will further secure the workplace and schools from COVID-19 infections. When administrators identify those who haven’t had the vaccine, they can make the appropriate decision to protect the majority,” said Shaun Passley, Ph.D., Chairman, and CEO of Epazz, Inc.

Pharmaceutical companies across the world are working double-time to create a vaccine against the Novel 2019 Coronavirus. One of the leading pharmaceutical companies, Pfizer, developed a vaccine with a promising result of 90percent effective according to the company’s clinical results. Over 43,538 volunteers participated and received two injections within 21 days apart. The company claimed that among the 94 evaluable COVID-19 cases, results revealed that more than 90% effectively prevented the Coronavirus infection. This result exceeded the Food and Drug Administration set a 50% minimum effectiveness bar. This promising result will pave the way for mass vaccinations if FDA approves the final stage of testing.

The Center for Disease Control and Prevention (CDC) and other collaborative health agencies initiated the Immunization Integration Program (IIP) four years ago. After clinicians found it challenging to keep track and improve adult vaccinations, the program started. The program’s goal was to help automate immunization-related tasks with an electronic health record and clinic software systems. Thus, with the digitalization of immunization records and schedules, the program aimed to increase vaccination rates within the adult population and secure these immunization records in cloud-based storage.